Avi Priel

Dr. Avi Priel

Pharmacology section, The Institute for Drug Research (IDR), The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Cell
Verified
Journal Article
Closed access
CBChristopher J. Bohlen
Christopher J. Bohlen
APAvi Priel
Avi Priel
SZSharleen Zhou
Sharleen Zhou
DKDavid King
David King
JSJan Siemens
Jan Siemens
DJDavid Julius
David Julius

9 March 2005 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
APAvi Priel
Avi Priel
AKAlexander Kolleker
Alexander Kolleker
GAGai Ayalon
Gai Ayalon
MGMoshe Gillor
Moshe Gillor
POPavel Osten
Pavel Osten
YSYael Stern-Bach
Yael Stern-Bach
The AMPA-type glutamate receptors mediate the majority of the fast excitatory synaptic transmission and critically contribute to synaptic plasticity in the brain, hence the existence of numerous trafficking proteins dedicated to regulation of their synaptic delivery and turnover. Stargazin (also termed γ2) is a member of a recently identified protein family termed transmembrane AMPA receptor regulatory proteins (TARPs). TARPs physically associate with AMPA receptors and participate in their surface delivery and anchoring at the postsynaptic membrane. Here, we report that next to its trafficking roles, stargazin may also act as a positive allosteric modulator of AMPA receptor ion channel function. Coexpression of stargazin with AMPA receptor subunits, either inXenopusoocytes or in human embryonic kidney 293 cells, significantly reduced receptor desensitization in response to glutamate. Receptor deactivation rates were also slowed, and the recovery from desensitization was accelerated. Structurally, based on the data showing a tight correlation between desensitization and the stability of the AMPA receptor intradimer interface, we propose that binding of stargazin may stabilize the receptor conformation. Functionally, our data suggest that AMPA receptors complexed with stargazin (and possibly also with other TARPs) at the postsynaptic membrane are significantly more responsive to synaptically released glutamate compared with AMPA receptors lacking stargazin/TARP interaction. The putative existence of such two states of synaptic AMPA receptors, with and without stargazin/TARP binding, may provide a novel mechanism for regulation of excitatory synaptic strength during development and/or in synaptic plasticity in the adult brain.

9 February 2004 in Journal of General Physiology
Verified
Journal Article
Open access
APAvi Priel
Avi Priel
SSShai D. Silberberg
Shai D. Silberberg
Ivermectin (IVM), a widely used antiparasitic agent in human and veterinary medicine, was recently shown to augment macroscopic currents through rat P2X4 receptor channels (Khakh, B.S., W.R. Proctor, T.V. Dunwiddie, C. Labarca, and H.A. Lester. 1999. J. Neurosci. 19:7289–7299.). In the present study, the effects of IVM on the human P2X4 (hP2X4) receptor channel stably transfected in HEK293 cells were investigated by recording membrane currents using the patch clamp technique. In whole-cell recordings, IVM (≤10 μM) applied from outside the cell (but not from inside) increased the maximum current activated by ATP, and slowed the rate of current deactivation. These two phenomena likely result from the binding of IVM to separate sites. A higher affinity site (EC50 0.25 μM) increased the maximal current activated by saturating concentrations of ATP without significantly changing the rate of current deactivation or the EC50 and Hill slope of the ATP concentration-response relationship. A lower affinity site (EC50 2 μM) slowed the rate of current deactivation, and increased the apparent affinity for ATP. In cell-attached patch recordings, P2X4 receptor channels exhibited complex kinetics, with multiple components in both the open and shut distributions. IVM (0.3 μM) increased the number of openings per burst, without significantly changing the mean open or mean shut time within a burst. At higher concentrations (1.5 μM) of IVM, two additional open time components of long duration were observed that gave rise to long-lasting bursts of channel activity. Together, the results suggest that the binding of IVM to the higher affinity site increases current amplitude by reducing channel desensitization, whereas the binding of IVM to the lower affinity site slows the deactivation of the current predominantly by stabilizing the open conformation of the channel.

13 October 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
LHLiad Hinden
Liad Hinden
SUShiran Udi
Shiran Udi
ADAdi Drori
Adi Drori
AGAsaad Gammal
Asaad Gammal
ANAlina Nemirovski
Alina Nemirovski
Joseph TamJoseph Tam
Joseph Tam
Altered glucose reabsorption via the facilitative glucose transporter 2 (GLUT2) during diabetes may lead to renal proximal tubule cell (RPTC) injury, inflammation, and interstitial fibrosis. These pathologies are also triggered by activating the cannabinoid-1 receptor (CB1R), which contributes to the development of diabetic nephropathy (DN). However, the link between CB1R and GLUT2 remains to be determined. Here, we show that chronic peripheral CB1R blockade or genetically inactivating CB1Rs in the RPTCs ameliorated diabetes-induced renal structural and functional changes, kidney inflammation, and tubulointerstitial fibrosis in mice. Inhibition of CB1R also downregulated GLUT2 expression, affected the dynamic translocation of GLUT2 to the brush border membrane of RPTCs, and reduced glucose reabsorption. Thus, targeting peripheral CB1R or inhibiting GLUT2 dynamics in RPTCs has the potential to treat and ameliorate DN. These findings may support the rationale for the clinical testing of peripherally restricted CB1R antagonists or the development of novel renal-specific GLUT2 inhibitors against DN.

7 March 2006 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
WMWeiyuan Ma
Weiyuan Ma
AKAlon Korngreen
Alon Korngreen
SWSimy Weil
Simy Weil
ECEnbal Ben‐Tal Cohen
Enbal Ben‐Tal Cohen
APAvi Priel
Avi Priel
SSShai D. Silberberg
Shai D. Silberberg
Airway ciliated cells express an ATP‐gated P2X receptor channel of unknown subunit composition (P2Xcilia) which is modulated by Na+and by long exposures to ATP. P2Xciliawas investigated by recording currents from freshly dissociated rabbit airway ciliated cells with the patch‐clamp technique in the whole‐cell configuration. During the initial continuous exposure to extracellular ATP, P2Xciliacurrents gradually increase in magnitude (priming), yet the permeability toN‐methyl‐d‐glucamine (NMDG) does not change, indicating that priming does not arise from a progressive change in pore diameter. Na+, which readily permeates P2Xciliareceptor channels, was found to inhibit the channel extracellular to the electric field. The rank order of permeability to various monovalent cations is: Li+, Na+, K+, Rb+, Cs+, NMDG+and TEA+, with a relative permeability of 1.35, 1.0, 0.99, 0.91, 0.79, 0.19 and 0.10, respectively. The rank order for the alkali cations follows an Eisenman series XI for a high‐strength field site. Ca2+has been estimated to be 7‐fold more permeant than Na+. The rise in [Ca2+]iin ciliated cells, induced by the activation of P2Xcilia, is largely inhibited by either Brilliant Blue G or KN‐62, indicating that P2X7may be a part of P2Xcilia. P2Xciliais augmented by Zn2+and by ivermectin, and P2X4receptor protein is detected by immunolabelling at the basal half of the cilia, strongly suggesting that P2X4is a component of P2Xciliareceptor channels. Taken together, these results suggest that P2Xciliais either assembled from P2X4and P2X7subunits, or formed from modified P2X4subunits.

1 December 2006 in Neuron
Verified
Journal Article
Closed access
APAvi Priel
Avi Priel
SSSanja Selak
Sanja Selak
JLJuan Lerma
Juan Lerma
YSYael Stern-Bach
Yael Stern-Bach